Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of Diablo polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse,Rat |
| Host species | Rabbit |
| Applications | IHC,WB-Ti |
More info about Diablo polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB9025 |
| Product name: | Diablo polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of Diablo. |
| Gene id: | 66593 |
| Gene name: | Diablo |
| Gene alias: | 0610041G12Rik|AU040403|Smac |
| Gene description: | diablo homolog (Drosophila) |
| Immunogen: | A synthetic peptide corresponding to residues surrounding amino acids 228 of human Diablo. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (0.5-4 ug/mL) Immunohistochemistry (5-20 mg/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS, pH 7.2 (30% glycerol, 0.5 mg/mL BSA, 0.01% thimerosal) |
| Storage instruction: | Store at -20°C. For long term storage store at -80°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains thimerosal: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Specificity: | The immunoaffinity purified antibody detects the 25 KDa Smac/DIABLO. |
| Reactivity: | Human,Mouse,Rat |
| Application image: |  |
| Application image note: | Western blot analysis of Diablo expression in human heart tissue lysate. |
| Applications: | IHC,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways.Haudek SB, Taffet GE, Schneider MD, Mann DL. J Clin Invest. 2007 Sep;117(9):2692-701. |